Details for Patent: 8,617,580

✉ Email this page to a colleague

Which drugs does patent 8,617,580 protect, and when does it expire?

Patent 8,617,580 protects TWYNEO and is included in one NDA.

This patent has twelve patent family members in ten countries.

Summary for Patent: 8,617,580

Title:	Compositions for topical application comprising a peroxide and retinoid
Abstract:	The invention relates to a composition for topical application comprising as an active ingredient a peroxide and a retinoid wherein one of said peroxide and retinoid is in the form of first microparticles comprising a solid particulate matter of the active ingredient coated by a metal oxide layer and the other of said peroxide and retinoid is present in an uncoated free form or in a coated form of the active ingredient. The invention further relates to method for treating a surface condition in a subject using said composition, a method for preparing a composition exhibiting improved stability, and a kit comprising: (a) a first composition comprising a peroxide as a first active ingredient; and (b) a second composition comprising a retinoid as a second active ingredient; at least one of said first and said second active ingredient being coated by a metal oxide layer.
Inventor(s):	Toledano; Ofer (Kfar-Saba, IL), Sertchook; Hanan (Gedera, IL), Loboda; Natalia (Jerusalem, IL), Bar-Simantov; Haim (Modiin, IL), Shapiro; Leora (Jerusalem, IL), Abu-Reziq; Raed (Jatt Hamesholash, IL)
Assignee:	Sol-Gel Technologies Ltd. (Ness Ziona, IL)
Application Number:	13/495,701
Patent Claim Types: see list of patent claims	Use; Composition; Device;

Drugs Protected by US Patent 8,617,580

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Galderma Labs Lp	TWYNEO	benzoyl peroxide; tretinoin	CREAM;TOPICAL	214902-001	Jul 26, 2021		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,617,580

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2008211553	⤷ Sign Up
Brazil	PI0808163	⤷ Sign Up
Canada	2677184	⤷ Sign Up
Eurasian Patent Organization	200970724	⤷ Sign Up
European Patent Office	2109445	⤷ Sign Up
Spain	2912051	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.